Barhemsys 5 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDD2R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,153
Award facts
- Contract value 100% obligated
- $23,152.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,152.98 delivery order to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of Barhemsys 5 mg/2 ml vials. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of February 4, 2026. Performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The parent company, Cencora, Inc., competes on a full and open basis for federal contracts and maintains significant contracts with multiple government agencies including the Department of Veterans Affairs and the Defense Logistics Agency. The Barhemsys supply under this delivery order supports DLA's medical supply chain operations and the broader mission of ensuring adequate pharmaceutical availability for Department of Defense healthcare facilities and personnel.
Quick answers
Who was awarded contract SPE2DR26FDD2R?
SPE2DR26FDD2R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26FDD2R worth?
The government has obligated $23,153 on SPE2DR26FDD2R.
Is contract SPE2DR26FDD2R an order under another contract?
Yes. SPE2DR26FDD2R is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDD2R competed?
The extent of competition for SPE2DR26FDD2R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award